FASTinov is a R&D intensive Startup with a patented disruptive technology to perform fast and reliable antimicrobial susceptibility tests.
FASTinov has raised $3.8M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
FASTinov's investors include Bynd Venture Capital, Explorer Investments, Armilar Venture Partners, Horizon 2020, Quilaban.
FASTinov is headquartered in Matosinhos, Portugal.
FASTinov is a R&D intensive Startup with a patented disruptive technology to perform fast and reliable antimicrobial susceptibility tests.
FASTinov is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"FASTinov — Funding & Investors." VCBacked, September 4, 2023, https://www.vcbacked.co/company/fastinov. Accessed August 14, 2026.
VCBacked. (2023). FASTinov — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/fastinov
{{cite web |title=FASTinov — Funding & Investors |url=https://www.vcbacked.co/company/fastinov |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated